SNY

Sanofi

Price

$47.64

return (12m)

p/e

7.21

p/bv

1.28

DIVIDEND YIELD

4.00%

SNY price

Sanofi

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment SNY

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals SNY

Valuation

P/E

7.21

Sector -2.34

Industry 11.10

P/BV

1.28

Sector 2.17

Industry 3.33

P/Revenue (PSR)

1.06

Sector 2.00

Industry 1.71

EV/EBITDA

14.34

Sector -23.69

Industry -398.52

EV/EBIT

33.50

Sector -36.60

Industry -80.73

P/EBITDA

4.12

Sector -0.10

Industry 8.30

P/EBIT

6.85

Sector -2.08

Industry 5.69

P/Total Assets

0.73

Sector 1.18

Industry 1.57

P/Net Current Assets

-3.81

Sector -10.91

Industry -3.38

P/Working Capital

35.29

Sector 0.09

Industry 10.51

EPS

6.12

Sector -0.93

Industry 1.10

BVPS

34.40

Sector 3.87

Industry 14.82

Efficiency

Gross Margin

71.19%

Sector 44.28%

Industry 29.23%

EBITDA Margin

26.87%

Sector -291.45%

Industry 4.29%

EBIT Margin

11.50%

Sector -195.44%

Industry 1.44%

Operating Margin

20.35%

Sector -25.72%

Industry 2.16%

Net Profit Margins

14.75%

Sector -30.19%

Industry 2.77%

Asset Turnover

0.20

Sector 0.12

Industry 0.27

Profitability

ROE

17.79%

Sector -34.71%

Industry 6.97%

ROA

10.06%

Sector -28.76%

Industry 2.97%

ROIC

8.49%

Sector -441.27%

Industry -5.31%

Dividends

Dividend yield

4.00%

Sector -

Industry 0.01%

Payout

28.84%

Sector -

Industry 0.54%

Debt

Current Ratio

1.09

Sector 1.87

Industry 1.51

Net Debt / EBITDA

0.85

Sector -2.18

Industry -1.68

Net Debt / EBIT

1.98

Sector -0.74

Industry -7.00

Net Debt / Equity

0.08

Sector -0.34

Industry 0.05

Gross Debt / Equity

0.20

Sector -0.64

Industry 0.35

Equity/Assets

0.57

Sector 0.43

Industry 0.46

Liabilities/Assets

0.43

Sector 0.46

Industry 0.52

Growth

5Y Revenue CAGR

17.30%

Sector -

Industry -

5Y Earnings CAGR

15.59%

Sector -

Industry -

FAIR VALUE OF Sanofi ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$47.64

Fair Value

$68.82

Upside Return potential.

44.47%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals SNY

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
SNY Sanofi	$47.64	-3.40%	4.00%	7.21	1.28	17.79%	14.75%
EW Edwards Lifesciences Corp.	$78.21	12.69%	0.00%	45.55	4.82	10.58%	17.34%
BSX Boston Scientific Corp.	$63.80	-31.89%	0.00%	18.45	2.54	13.78%	17.29%
ABT Abbott Laboratories	$101.06	-18.35%	0.00%	25.64	3.09	12.06%	13.91%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
ALGN Align Technology Inc.	$184.69	12.52%	0.00%	27.86	2.89	10.36%	10.50%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

SNY Historical Dividends

current DY: 4.00%

5-year average DY: 4.38%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	05/09/2025	06/12/2025	2.21210000
Dividends	05/10/2024	06/06/2024	2.03740000
Dividends	05/31/2023	06/23/2023	1.90310000
Dividends	05/05/2022	06/08/2022	1.79680000
Dividends	05/04/2021	05/26/2021	1.90610000
Dividends	05/01/2020	05/26/2020	1.75300000
Dividends	05/08/2019	05/31/2019	1.73900000
Dividends	05/10/2018	06/04/2018	1.86100000
Dividends	05/15/2017	06/07/2017	1.57700000
Dividends	05/09/2016	06/01/2016	1.63000000
Dividends	05/08/2015	06/02/2015	1.60930000
Dividends	05/09/2014	06/05/2014	1.90980000
Dividends	05/08/2013	06/05/2013	1.86200000
Dividends	05/09/2012	05/30/2012	1.75600000
Dividends	05/13/2011	06/24/2011	1.82200000
Dividends	05/19/2010	06/14/2010	1.62700000
Dividends	04/22/2009	05/29/2009	1.41900000
Dividends	05/20/2008	06/13/2008	1.51000000
Dividends	06/06/2007	07/03/2007	1.14500000
Dividends	06/06/2006	07/03/2006	0.91200000
Dividends	06/06/2005	07/01/2005	0.79900000
Dividends	09/29/2004	10/05/2004	0.03080000
Dividends	05/04/2004	06/01/2004	0.58000000
Dividends	05/30/2003	06/26/2003	0.46200000

ABOUT Sanofi

Sanofi

Average Investor10 user rating

4.0 (0 people)

States of America

32 years

Founded: 1994

2002

Time since IPO - 24 years

99.412

Employees

Sanofi (States of America) is listed on the Nasdaq and has a market capitalization of $107.73 billion, with shareholders equity totaling $83.97 billion.

The company employs approximately 99.412 people and operates in the Saúde sector, within the Produtos Farmacêuticos industry.

Over the past 12 months, Sanofi reported $101.28 billion in revenue, generating net income of $14.93 billion.

Key financial metrics include a P/E ratio of 7.21, a price-to-book (P/B) ratio of 1.28, and a trailing twelve-month dividend yield of 4.00%.

The company trades under the ticker SNY.

Market cap

$107.73 billion

Net worth

$83.97 billion

$83,969,550,000.00

Assets

$148.48 billion

$148,483,610,000.00

Total Shares Outstanding

2.44 billion

2,441,000,000

Average Daily Trading Volume

$3.31 million

$3,306,778.00

Sector

Saúde

Industry

Produtos Farmacêuticos

SNY

revenue by Business Segment Sanofi

SNY revenue and profits

Financial Results SNY

DRAG THE FRAME TO SEE MORE DATA

SNY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$77.63 34,88% (12M)

P/E

46.88

2.46%

ROE

3.78%

P/BV

1.77

CI - Cigna

$272.65 --5,23% (12M)

P/E

11.58

2.16%

ROE

15.39%

P/BV

1.78

CNC - Centene

$37.26 38,72% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$196.30 --14,19% (12M)

P/E

42.07

0.89%

ROE

6.06%

P/BV

2.55

LLY - Eli Lilly

$923.03 21,62% (12M)

P/E

41.74

0.55%

ROE

81.02%

P/BV

33.82

HCA - HCA Healthcare

$498.78 47,18% (12M)

P/E

12.41

0.80%

ROE

-228.14%

P/BV

-28.31

NVS - Novartis

$153.41 34,63% (12M)

P/E

21.74

2.01%

ROE

34.77%

P/BV

7.56

ABT - Abbott

$101.06 --18,39% (12M)

P/E

25.64

0.00%

ROE

12.06%

P/BV

3.09